Latest News
News Functions
Additional Functions
4 May 2020
PreveCeutical Medical Inc.
PreveCeutical Announces Possible Viral Prevention Program Using CBD Sol-gel
23 January 2020
PreveCeutical Medical Inc.
PreveCeutical Retains Patent Legal Team
14 January 2020
PreveCeutical Medical Inc.
PreveCeutical Announces Further Updates to the Successful Engineering & Cell-Based Efficacy Screening of its Smart-siRNA Constructs for its Dual Gene Therapy Research Program
8 January 2020
PreveCeutical Medical Inc.
PreveCeutical Announces Positive Results Following a Preliminary Safety Evaluation of Sol-Gel Formulations When Applied to Human Nasal Tissue
29 October 2019
PreveCeutical Medical Inc.
PreveCeutical Announces Successful Completion from its Design, Synthesis and Preliminary Evaluation of Novel Designed Peptides Derived from Caribbean Blue Scorpion Venom in a Cell-Based Brain Cancer Model
7 October 2019
PreveCeutical Medical Inc.
PreveCeutical Receives $616,802 AUD Research and Development Tax Incentive Cash Refund
23 September 2019
PreveCeutical Medical Inc.
PreveCeutical Announces the Successful Engineering & Cell-Based Efficacy Screening of its Smart-siRNA Constructs for its Dual Gene Therapy Research Program
3 September 2019
PreveCeutical Medical Inc.
PreveCeutical Reaches Milestone in Research Program for Development of Non-Addictive Analgesics
6 August 2019
PreveCeutical Medical Inc.
PreveCeutical Grants Asterion Option to Purchase up to a 51% Interest in Sol-Gel Intellectual Property
PreveCeutical Medical Inc.
PreveCeutical Grants Asterion Option to Purchase up to a 51% Interest in Sol-Gel Intellectual Property
9 July 2019
PreveCeutical Medical Inc.
PreveCeutical Successfully Incorporates Medicinal Cannabis Extracts into the Sol-Gel Drug Delivery System
17 June 2019
PreveCeutical Medical Inc.
PreveCeutical Announces Further Positive Results from its Dual Gene Therapy Research Program
3 June 2019
PreveCeutical Medical Inc.
PreveCeutical Secures $300,000 Loan and Resignation of a Director
21 May 2019
PreveCeutical Medical Inc.
PreveCeutical Granted Approval to Acquire and Use Human Mucosal Tissue for Final Phase of Sol-Gel Program
17 April 2019
PreveCeutical Medical Inc.
PreveCeutical Partnership Leads to Two New Patent Filings
15 April 2019
PreveCeutical Medical Inc.
PreveCeutical Files Application to Human Ethics Committee to Acquire Human Tissue for the Final Phase of the Sol-Gel Program
10 April 2019
PreveCeutical Medical Inc.
PreveCeutical Announces Further Results from its Preliminary Screening of Peptides Derived from Blue Scorpion Venom in a Cell-Based Brain Cancer Model
8 April 2019
PreveCeutical Medical Inc.
PreveCeutical Announces Default Judgment Against JCN Capital Corp.
4 April 2019
PreveCeutical Medical Inc.
Asterion Welcomes Australian Government Awarding of Major Project Status for its Toowoomba Medicinal Cannabis Project
PreveCeutical Medical Inc.
Asterion Welcomes Australian Government Awarding of Major Project Status for its Toowoomba Medicinal Cannabis Project
25 March 2019
PreveCeutical Medical Inc.
PreveCeutical Announces Default Judgment Against Essos Corporate Services Inc. and Detona Capital Corp.
11 March 2019
PreveCeutical Medical Inc.
PreveCeutical Announces Preliminary Screening Results of Peptides Derived From Blue Scorpion Venom in a Cell-Based Brain Cancer Model
13 February 2019
PreveCeutical Medical Inc.
PreveCeutical Announces Appointment of Dr. Makarand Jawadekar as President
29 January 2019
PreveCeutical Medical Inc.
PreveCeutical to Explore Partnerships with Pharmaceutical and Biotechnology Companies for the Co-Development of its Sol-Gel System
14 January 2019
PreveCeutical Medical Inc.
PreveCeutical Provides Update on the Dual Gene Therapy Program
8 January 2019
PreveCeutical Medical Inc.
PreveCeutical Provides Update on Research Program for Development of Non-Addictive Analgesics
7 January 2019
PreveCeutical Medical Inc.
PreveCeutical Files Notice of Civil Claim Against the BridgeMark Group
20 November 2018
PreveCeutical Medical Inc.
PreveCeutical Converts Acidic Phytocannabinoids to Neutral Form and Doubles Contents of Fingerprinted Cannabis Extract Library
19 November 2018
PreveCeutical Medical Inc.
PreveCeutical Confirms Encouraging Results from Sol-gel Applicator Trials for Achieving Direct Nose-to-Brain Delivery in an Adult Human Nasal Cast
13 November 2018
PreveCeutical Medical Inc.
PreveCeutical Announces LOI with Crushedit LLC to Supply CBD Isolate for Expected Sale Proceeds of $16.25 Million